A citation-based method for searching scientific literature

Youri Hoogstrate, Santoesha A Ghisai, Maurice de Wit, Iris de Heer, Kaspar Draaisma, Job van Riet, Harmen J G van de Werken, Vincent Bours, Jan Buter, Isabelle Vanden Bempt, Marica Eoli, Enrico Franceschi, Jean-Sebastien Frenel, Thierry Gorlia, Monique C Hanse, Ann Hoeben, Melissa Kerkhof, Johan M Kros, Sieger Leenstra, Giuseppe Lombardi, Slávka Lukacova, Pierre A Robe, Juan M Sepulveda, Walter Taal, Martin Taphoorn, René M Vernhout, Annemiek M E Walenkamp, Colin Watts, Michael Weller, Filip Y F de Vos, Guido W Jenster, Martin van den Bent, Pim J French. Neuro Oncol 2022
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


FBXL2 counteracts Grp94 to destabilize EGFR and inhibit EGFR-driven NSCLC growth.
Mengmeng Niu, Jing Xu, Yang Liu, Yuhuang Li, Tao He, Liangping Ding, Yajun He, Yong Yi, Fengtian Li, Rongtian Guo,[...]. Nat Commun 2021
4
100


Expanding the search for significant EGFR mutations in NSCLC outside of the tyrosine kinase domain with next-generation sequencing.
Matthew K Stein, Lindsay Morris, Jennifer L Sullivan, Moon Fenton, Ari VanderWalde, Lee S Schwartzberg, Mike G Martin. Med Oncol 2017
1
100

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018.
Quinn T Ostrom, Gino Cioffi, Kristin Waite, Carol Kruchko, Jill S Barnholtz-Sloan. Neuro Oncol 2021
122
100

Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1.
G Levkowitz, H Waterman, S A Ettenberg, M Katz, A Y Tsygankov, I Alroy, S Lavi, K Iwai, Y Reiss, A Ciechanover,[...]. Mol Cell 1999
797
100

Clinical implication of cellular vaccine in glioma: current advances and future prospects.
Yuanliang Yan, Shuangshuang Zeng, Zhicheng Gong, Zhijie Xu. J Exp Clin Cancer Res 2020
15
100


Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis.
Robert M Bachoo, Elizabeth A Maher, Keith L Ligon, Norman E Sharpless, Suzanne S Chan, Mingjian James You, Yi Tang, Jessica DeFrances, Elizabeth Stover, Ralph Weissleder,[...]. Cancer Cell 2002
491
100

The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma.
Fangling Cheng, Po Zhang, Qungen Xiao, Youwei Li, Minhai Dong, Heping Wang, Dong Kuang, Yue He, Qiuhong Duan, Feng Mao,[...]. Front Oncol 2019
5
100

Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment.
Natalia Jura, Nicholas F Endres, Kate Engel, Sebastian Deindl, Rahul Das, Meindert H Lamers, David E Wemmer, Xuewu Zhang, John Kuriyan. Cell 2009
406
100

EAI045: The fourth-generation EGFR inhibitor overcoming T790M and C797S resistance.
Shuhang Wang, Yongping Song, Delong Liu. Cancer Lett 2017
137
100

Discovery of a potent and selective EGFR inhibitor (AZD9291) of both sensitizing and T790M resistance mutations that spares the wild type form of the receptor.
M Raymond V Finlay, Mark Anderton, Susan Ashton, Peter Ballard, Paul A Bethel, Matthew R Box, Robert H Bradbury, Simon J Brown, Sam Butterworth, Andrew Campbell,[...]. J Med Chem 2014
314
100

Potential Therapy for Refractory Colon Cancer.
Mitch Leslie. Cancer Discov 2016
4
100

SWISS-MODEL: homology modelling of protein structures and complexes.
Andrew Waterhouse, Martino Bertoni, Stefan Bienert, Gabriel Studer, Gerardo Tauriello, Rafal Gumienny, Florian T Heer, Tjaart A P de Beer, Christine Rempfer, Lorenza Bordoli,[...]. Nucleic Acids Res 2018
100

LRIG3 Suppresses Angiogenesis by Regulating the PI3K/AKT/VEGFA Signaling Pathway in Glioma.
Chenghao Peng, Hanmin Chen, Youwei Li, Hang Yang, Peizhong Qin, Baojun Ma, Qiuhong Duan, Baofeng Wang, Feng Mao, Dongsheng Guo. Front Oncol 2021
4
100

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.
Ethan Cerami, Jianjiong Gao, Ugur Dogrusoz, Benjamin E Gross, Selcuk Onur Sumer, Bülent Arman Aksoy, Anders Jacobsen, Caitlin J Byrne, Michael L Heuer, Erik Larsson,[...]. Cancer Discov 2012
100

High-throughput Phenotyping of Lung Cancer Somatic Mutations.
Alice H Berger, Angela N Brooks, Xiaoyun Wu, Yashaswi Shrestha, Candace Chouinard, Federica Piccioni, Mukta Bagul, Atanas Kamburov, Marcin Imielinski, Larson Hogstrom,[...]. Cancer Cell 2016
115
100

Gefitinib selectively inhibits tumor cell migration in EGFR-amplified human glioblastoma.
Jonathon J Parker, Kalen R Dionne, Rada Massarwa, Marci Klaassen, Nicholas K Foreman, Lee Niswander, Peter Canoll, B K Kleinschmidt-Demasters, Allen Waziri. Neuro Oncol 2013
31
100

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.
Jianjiong Gao, Bülent Arman Aksoy, Ugur Dogrusoz, Gideon Dresdner, Benjamin Gross, S Onur Sumer, Yichao Sun, Anders Jacobsen, Rileen Sinha, Erik Larsson,[...]. Sci Signal 2013
100

Inhibition of DHHC20-Mediated EGFR Palmitoylation Creates a Dependence on EGFR Signaling.
Kristin B Runkle, Akriti Kharbanda, Ewa Stypulkowski, Xing-Jun Cao, Wei Wang, Benjamin A Garcia, Eric S Witze. Mol Cell 2016
82
100

MICAL2 Mediates p53 Ubiquitin Degradation through Oxidating p53 Methionine 40 and 160 and Promotes Colorectal Cancer Malignance.
Jinping Lu, Yuejin Li, Yuanzhong Wu, Shan Zhou, Chaojun Duan, Zigang Dong, Tiebang Kang, Faqing Tang. Theranostics 2018
13
100

Effective Treatment of Lung Adenocarcinoma Harboring EGFR-Activating Mutation, T790M, and cis-C797S Triple Mutations by Brigatinib and Cetuximab Combination Therapy.
Yubo Wang, Nong Yang, Yongchang Zhang, Li Li, Rui Han, Mengxiao Zhu, Mingxia Feng, Hengyi Chen, Analyn Lizaso, Tian Qin,[...]. J Thorac Oncol 2020
23
100

Novel mode for neutrophil protease cathepsin G-mediated signaling: membrane shedding of epidermal growth factor is required for cardiomyocyte anoikis.
Khadija Rafiq, Marie Hanscom, Kristoffer Valerie, Susan F Steinberg, Abdelkarim Sabri. Circ Res 2008
19
100

Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastoma.
Laura A Johnson, John Scholler, Takayuki Ohkuri, Akemi Kosaka, Prachi R Patel, Shannon E McGettigan, Arben K Nace, Tzvete Dentchev, Pramod Thekkat, Andreas Loew,[...]. Sci Transl Med 2015
291
100

Role of ErbB Receptors in Cancer Cell Migration and Invasion.
Aline Appert-Collin, Pierre Hubert, Gérard Crémel, Amar Bennasroune. Front Pharmacol 2015
173
100

Small molecules, big impact: 20 years of targeted therapy in oncology.
Philippe L Bedard, David M Hyman, Matthew S Davids, Lillian L Siu. Lancet 2020
119
100

Management of glioblastoma: State of the art and future directions.
Aaron C Tan, David M Ashley, Giselle Y López, Michael Malinzak, Henry S Friedman, Mustafa Khasraw. CA Cancer J Clin 2020
345
100

Epidermal Growth Factor Receptor Extracellular Domain Mutations in Glioblastoma Present Opportunities for Clinical Imaging and Therapeutic Development.
Zev A Binder, Amy Haseley Thorne, Spyridon Bakas, E Paul Wileyto, Michel Bilello, Hamed Akbari, Saima Rathore, Sung Min Ha, Logan Zhang, Cole J Ferguson,[...]. Cancer Cell 2018
84
100

ErbB receptor tyrosine kinase network inhibition radiosensitizes carcinoma cells.
Joseph N Contessa, Angela Abell, Kristoffer Valerie, Peck-Sun Lin, Rupert K Schmidt-Ullrich. Int J Radiat Oncol Biol Phys 2006
16
100

The third-generation EGFR inhibitor AZD9291 overcomes primary resistance by continuously blocking ERK signaling in glioblastoma.
Xuejiao Liu, Xiangyu Chen, Lin Shi, Qianqian Shan, Qiyu Cao, Chenglong Yue, Huan Li, Shengsheng Li, Jie Wang, Shangfeng Gao,[...]. J Exp Clin Cancer Res 2019
45
100

The somatic genomic landscape of glioblastoma.
Cameron W Brennan, Roel G W Verhaak, Aaron McKenna, Benito Campos, Houtan Noushmehr, Sofie R Salama, Siyuan Zheng, Debyani Chakravarty, J Zachary Sanborn, Samuel H Berman,[...]. Cell 2013
100

EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation.
Eskil Eskilsson, Gro V Rosland, Krishna M Talasila, Stian Knappskog, Olivier Keunen, Andrea Sottoriva, Sarah Foerster, Gergely Solecki, Torfinn Taxt, Radovan Jirik,[...]. Neuro Oncol 2016
60
100

Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain.
Fangtian Huang, Donald Kirkpatrick, Xuejun Jiang, Steven Gygi, Alexander Sorkin. Mol Cell 2006
405
100

Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance.
Kazuhiro Tanaka, Ivan Babic, David Nathanson, David Akhavan, Deliang Guo, Beatrice Gini, Julie Dang, Shaojun Zhu, Huijun Yang, Jason De Jesus,[...]. Cancer Discov 2011
224
100

AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer.
Darren A E Cross, Susan E Ashton, Serban Ghiorghiu, Cath Eberlein, Caroline A Nebhan, Paula J Spitzler, Jonathon P Orme, M Raymond V Finlay, Richard A Ward, Martine J Mellor,[...]. Cancer Discov 2014
100

Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain.
Jeffrey C Lee, Igor Vivanco, Rameen Beroukhim, Julie H Y Huang, Whei L Feng, Ralph M DeBiasi, Koji Yoshimoto, Jennifer C King, Phioanh Nghiemphu, Yuki Yuza,[...]. PLoS Med 2006
236
100

Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer.
Beth O Van Emburgh, Sabrina Arena, Giulia Siravegna, Luca Lazzari, Giovanni Crisafulli, Giorgio Corti, Benedetta Mussolin, Federica Baldi, Michela Buscarino, Alice Bartolini,[...]. Nat Commun 2016
124
100

Discovery and saturation analysis of cancer genes across 21 tumour types.
Michael S Lawrence, Petar Stojanov, Craig H Mermel, James T Robinson, Levi A Garraway, Todd R Golub, Matthew Meyerson, Stacey B Gabriel, Eric S Lander, Gad Getz. Nature 2014
100

Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma.
Sith Sathornsumetee, Annick Desjardins, James J Vredenburgh, Roger E McLendon, Jennifer Marcello, James E Herndon, Alyssa Mathe, Marta Hamilton, Jeremy N Rich, Julie A Norfleet,[...]. Neuro Oncol 2010
159
100

TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic target.
Jiao-Jiao Yu, Dan-Dan Zhou, Xiao-Xiao Yang, Bing Cui, Feng-Wei Tan, Junjian Wang, Ke Li, Shuang Shang, Cheng Zhang, Xiao-Xi Lv,[...]. Nat Commun 2020
25
100

EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis.
Krishna M Talasila, Anke Soentgerath, Philipp Euskirchen, Gro V Rosland, Jian Wang, Peter C Huszthy, Lars Prestegarden, Kai Ove Skaftnesmo, Per Øystein Sakariassen, Eskil Eskilsson,[...]. Acta Neuropathol 2013
95
100

Primary glioblastoma cells for precision medicine: a quantitative portrait of genomic (in)stability during the first 30 passages.
Sathishkumar Baskaran, Markus Mayrhofer, Hanna Göransson Kultima, Tobias Bergström, Lioudmila Elfineh, Lucia Cavelier, Anders Isaksson, Sven Nelander. Neuro Oncol 2018
14
100

Clinical impact of subclonal EGFR T790M mutations in advanced-stage EGFR-mutant non-small-cell lung cancers.
Tereza Vaclova, Ursula Grazini, Lewis Ward, Daniel O'Neill, Aleksandra Markovets, Xiangning Huang, Juliann Chmielecki, Ryan Hartmaier, Kenneth S Thress, Paul D Smith,[...]. Nat Commun 2021
13
100

Clathrin-independent endocytosis of ubiquitinated cargos.
Sara Sigismund, Tanja Woelk, Claudia Puri, Elena Maspero, Carlo Tacchetti, Pietro Transidico, Pier Paolo Di Fiore, Simona Polo. Proc Natl Acad Sci U S A 2005
631
100

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.
Thomas J Lynch, Daphne W Bell, Raffaella Sordella, Sarada Gurubhagavatula, Ross A Okimoto, Brian W Brannigan, Patricia L Harris, Sara M Haserlat, Jeffrey G Supko, Frank G Haluska,[...]. N Engl J Med 2004
100

The inducible expression of dominant-negative epidermal growth factor receptor-CD533 results in radiosensitization of human mammary carcinoma cells.
J N Contessa, D B Reardon, D Todd, P Dent, R B Mikkelsen, K Valerie, G D Bowers, R K Schmidt-Ullrich. Clin Cancer Res 1999
69
100

Extrachromosomal oncogene amplification in tumour pathogenesis and evolution.
Roel G W Verhaak, Vineet Bafna, Paul S Mischel. Nat Rev Cancer 2019
101
100

The deubiquitinase UCHL1 regulates cardiac hypertrophy by stabilizing epidermal growth factor receptor.
Hai-Lian Bi, Xiao-Li Zhang, Yun-Long Zhang, Xin Xie, Yun-Long Xia, Jie Du, Hui-Hua Li. Sci Adv 2020
25
100

RIN1 orchestrates the activation of RAB5 GTPases and ABL tyrosine kinases to determine the fate of EGFR.
Kavitha Balaji, Chelsea Mooser, Christine M Janson, Joanne M Bliss, Houmehr Hojjat, John Colicelli. J Cell Sci 2012
38
100

EGFR heterogeneity and implications for therapeutic intervention in glioblastoma.
Eskil Eskilsson, Gro V Røsland, Gergely Solecki, Qianghu Wang, Patrick N Harter, Grazia Graziani, Roel G W Verhaak, Frank Winkler, Rolf Bjerkvig, Hrvoje Miletic. Neuro Oncol 2018
115
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.